(Q43932430)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11913731%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Serotonin transporter gene associated with lithium prophylaxis in mood disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11913731%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

0 references

R Lilli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11913731%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

L Mandelli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11913731%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C Lorenzi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11913731%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11913731%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11913731%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11913731%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11913731%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

71-77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11913731%20AND%20SRC:MED&resulttype=core&format=json

The search for genetic homogeneity in affective disorders

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Outcomes on lithium treatment as a tool for genetic studies in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Lithium Increases Serotonin Release and Decreases Serotonin Receptors in the Hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Effects of chronic lithium treatment on serotonin binding sites in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Regulation of central serotonin transporters by chronic lithium: an autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Long-term lithium treatment causes serotonin receptor down-regulation via serotonergic presynapses in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Serotonin does not mediate the adrenal catecholamine-releasing effect of acute lithium administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Lithium reduced synaptic transmission and increased neuronal excitability without altering endogenous serotonin, norepinephrine and dopamine in rat hippocampal slices in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Lithium and serotonin function: implications for the serotonin hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Serotonin transporter gene and risk for bipolar affective disorder: an association study in Spanish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Behavioral effects of tryptophan depletion in seasonal affective disorder associated with the serotonin transporter gene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Association of a functional polymorphism of the serotonin transporter gene with anxiety-related temperament and behavior problems in children: a longitudinal study from infancy to the mid-teens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Association between serotonin transporter gene polymorphism and anxiety-related traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Anxiety traits associated with a polymorphism in the serotonin transporter gene regulatory region in the Japanese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Serotonin transporter (5-HTT) gene variants associated with autism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Evidence of linkage between the serotonin transporter and autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Serotonin transporter gene is not associated with symptomatology of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

PI, GC, HP, and TF serum protein polymorphisms in Siena, Tuscany, Italy, with a review of data for Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

A manic depressive history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Does effective lithium prophylaxis result in a symptom-free state of manic-depressive illness? Some thoughts on the fine-tuning of mood stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Does lithium treatment still work? Evidence of stable responses over three decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

A diagnostic interview: the schedule for affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Best estimate of lifetime psychiatric diagnosis: a methodological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Serotonin transporter gene and manic depressive illness: An association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

No association between chromosome-18 markers and lithiumresponsive affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Outcome of bipolar disorder on long-term treatment with lithium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Early onset of lithium prophylaxis as a predictor of good long-term outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Melancholic features and response to lithium prophylaxis in mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Genetic history as a predictor of lithium response in manic-depressive illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Lithium response and genetics of affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Serotonergic mechanisms in psychiatric disorders: new research tools, new ideas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Chronic lithium administration enhances serotonin release in the lateral hypothalamus but not in the hippocampus in rats. A microdialysis study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

The effects of antidepressant treatments and lithium upon 5-HT1A receptor function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Tryptophan depletion in recently manic patients treated with lithium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

The serotonin transporter is a potential susceptibility factor for bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

A functional variant of the serotonin transporter gene in families with bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Association analysis of 5HT transporter gene in bipolar disorder in the Indian population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Study of the association between the serotonin transporter gene regulatory region polymorphism and personality traits in a Japanese population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Association between anxiety disorders and a functional polymorphism in the serotonin transporter gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Does the short variant of the serotonin transporter linked polymorphic region constitute a marker of alcohol dependence?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

The serotonin transporter in the midbrain of suicide victims with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Serotonin transporter gene polymorphism and schizophrenia: an association study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Schizophrenia and the serotonin transporter gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Serotonin transporter gene and schizophrenia: evidence for association/linkage disequilibrium in families with affected siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Serotonin transporter gene not associated with psychotic symptomatology of mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders11This work was partially supported by the BIOMED 2 grant BMH4-CT97-2307

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Serotonin transporter gene regulatory region polymorphism and panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Symptomatologic analysis of psychotic and non-psychotic depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Clinical and demographic features of psychotic and nonpsychotic depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

A long-term retrospective follow-up study of patients treated with prophylactic lithium carbonate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

European Collaborative Project on Affective Disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

A study of relapses in subjects with mood disorder on lithium treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021

A 24-month follow-up study of unipolar subjects: a comparison between lithium and fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500006

7 January 2021